Help WHO revise its guidelines!

The WHO are currently preparing updates to its Medical Eligibility Criteria for Contraceptive Use and Selected Practice Recommendations for Contraceptive Use, which will be finalized in 2014, and are soliciting feedback from various stakeholders in the field of family planning to inform this process. The goal is to ensure these guidelines remain relevant to family planning […]

Read More…

April Journal – 20th Anniversary of the FSRH

Hightlights from this edition include: The FSRH’s 20th anniversary It is 20 years since the establishment of the Faculty of Sexual and Reproductive Healthcare (FSRH). In celebrating its anniversary there is much to be proud of, and indeed Community Sexual and Reproductive Health is now a specialty in its own right. Readers should find the story […]

Read More…

New RCN publication: Genital examination in women – A resource for skills development and assessment. The purpose of the document is to provide standards and sample assessment tools for training in genital examination in women for nurses working in sexual and reproductive health settings, and related health and social care settings. It replaces the earlier […]

Read More…

Sexual health improvement framework, comments and other News

‘A Framework for Sexual Health Improvement in England’ sets out the government’s ambitions for improving sexual health. Designed to be used by local organisations when they are looking at how best to provide sexual health services in their area. This includes the need for: a fall in the number of unwanted pregnancies  greater efforts to […]

Read More…

Depo-Provera does not increase fracture risk.

Results from a new study published in the March issue of Obstetrics and Gynaecology demonstrate that the use of depot medroxyprogesterone acetate (DMPA) does not appear to increase fracture risk. Whilst the use of DMPA reduces serum oestrogen levels and is associated with significant loss of bone mineral density (BMD), this study shows that it […]

Read More…

Journal Online First

The following Online Firsts have been published Does a full bladder assist insertion of intrauterine contraception?: a randomised trial (Cameron, Glasier, Cooper,  Johnstone) Cameron and colleagues set out to answer a simple question: does a full bladder assist insertion of intrauterine contraception? In the world of assisted conception a full bladder had been shown to […]

Read More…

Press Releases: Risk of Unwanted Pregnancies with Morning After Pill Conscience Clause & Cuts to services set to cost UK £136.7 billion

Risk of Unwanted Pregnancies with Morning After Pill Conscience Clause This article is published in the Journal of Medical Ethics today – “The Fox and the grapes: an Anglo-Irish perspective on conscientious objection to the supply of emergency hormonal contraception without prescription” Conscience clauses, which allow pharmacists to opt out of providing the “morning after […]

Read More…

SRH News

Education for Choice hightlights misleading pregnancy counselling Education for Choice support young people’s right to informed choice on abortion. They report that Feminist Action Cambridge held a demo in Cambridge city centre to raise awareness of local ‘crisis pregnancy centres’ which they feel are ‘using emotionally manipulative techniques’ and misinformation ‘in order to increase the […]

Read More…

Some ‘Online Firsts’ and News

The following papers have been published at http://jfprhc.bmj.com/content/early/recent The financial costs to patients of diagnosing and excluding ectopic pregnancy (Unger et al) In their article, Unger and his colleagues in Edinburgh report on their assessment of an area of patient experience that is not often considered when assessing medical interventions. The financial impact on patients’ […]

Read More…

Drugs – What’s in a name?

Branded, generics or branded generics? Do you know the difference? When a branded, or proprietary, drug comes ‘off patent’ it is common for other companies to apply for marketing authorisation and we are, increasingly, seeing this in sexual health. This can be for generic versions or for branded generics. Branded generics are simply generic equivalent […]

Read More…